Abstract 7766: Single-dose neoadjuvant atezolizumab in resectable stage IA-IIIA non-N2 NSCLC: Tumor infiltrate analysis from the PRINCEPS trial
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Antonio Nuccio, Lydie Cassard, Nathalie Cozic, Malek Ben Salah, Vesna Lukic, Julien Adam, Wael Salem Zrafi, David Planchard, Jordi Remon, Pernelle Lavaud, Anas Gazzah, Vincent Thomas de Montpreville, Maria Rosa Ghigna, Patrick Dumont, Elie Fadel, Fabrice Barlesi, Caroline Caramella, Filippo Gustavo Dall’Olio, Olaf Mercier, Paul-Henry Cournède, Nathalie Chaput, Benjamin Besse
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148824899
Cites:
Cited by:
Related to: